Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-Bβ JH Kurzer, LS Argetsinger, YJ Zhou, JLK Kouadio, JJ O'Shea, C Carter-Su Molecular and cellular biology 24 (10), 4557-4570, 2004 | 148 | 2004 |
SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other TJ Maures, JH Kurzer, C Carter-Su Trends in Endocrinology & Metabolism 18 (1), 38-45, 2007 | 131 | 2007 |
High frequency of SARS-CoV-2 RNAemia and association with severe disease CA Hogan, BA Stevens, MK Sahoo, CH Huang, N Garamani, S Gombar, ... Clinical Infectious Diseases 72 (9), e291-e295, 2021 | 119 | 2021 |
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML OK Weinberg, A Siddon, YF Madanat, J Gagan, DA Arber, P Dal Cin, ... Blood advances 6 (9), 2847-2853, 2022 | 104 | 2022 |
Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state JH Kurzer, P Saharinen, O Silvennoinen, C Carter-Su Molecular and cellular biology 26 (17), 6381-6394, 2006 | 56 | 2006 |
E2A-PBX1 remodels oncogenic signaling networks in B-cell precursor acute lymphoid leukemia J Duque-Afonso, CH Lin, K Han, MC Wei, J Feng, JH Kurzer, ... Cancer research 76 (23), 6937-6949, 2016 | 36 | 2016 |
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone … OK Weinberg, RP Hasserjian, E Baraban, CY Ok, JT Geyer, JKSS Philip, ... Modern Pathology 32 (9), 1373-1385, 2019 | 31 | 2019 |
SETDB2 links E2A-PBX1 to cell-cycle dysregulation in acute leukemia through CDKN2C repression CH Lin, SHK Wong, JH Kurzer, C Schneidawind, MC Wei, ... Cell reports 23 (4), 1166-1177, 2018 | 27 | 2018 |
PHF6 Mutations in Hematologic Malignancies JH Kurzer, OK Weinberg Frontiers in Oncology 11, 704471, 2021 | 26 | 2021 |
Acute leukemias of ambiguous lineage: clarification on lineage specificity JH Kurzer, OK Weinberg Surgical Pathology Clinics 12 (3), 687-697, 2019 | 19 | 2019 |
Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival RC Johnson, JH Kurzer, PL Greenberg, D Gratzinger American journal of clinical pathology 142 (6), 795-802, 2014 | 19 | 2014 |
Comparison of a point-of-care assay and a high-complexity assay for detection of SARS-CoV-2 RNA B Stevens, CA Hogan, MK Sahoo, CH Huang, N Garamani, J Zehnder, ... The Journal of Applied Laboratory Medicine 5 (6), 1307-1312, 2020 | 15 | 2020 |
Flow immunophenotyping of benign lymph nodes sampled by FNA: representative with diagnostic pitfalls GD Scott, HD Lau, JH Kurzer, CS Kong, DA Gratzinger Cancer cytopathology 126 (9), 797-808, 2018 | 13 | 2018 |
Impact of pretransplant donor BK viruria in kidney transplant recipients SK Tan, C Huang, MK Sahoo, J Weber, J Kurzer, MR Stedman, ... The Journal of Infectious Diseases 220 (3), 370-376, 2019 | 12 | 2019 |
To B‐or not to B‐: A review of lineage switched acute leukemia JH Kurzer, OK Weinberg International Journal of Laboratory Hematology 44, 64-70, 2022 | 10 | 2022 |
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group OK Weinberg, KM Chisholm, CY Ok, Y Fedoriw, B Grzywacz, JH Kurzer, ... Modern Pathology 34 (7), 1358-1366, 2021 | 9 | 2021 |
Growth hormone induced activation and regulation of Jak2 and Stat proteins JH Kurzer, C Carter-Su Signal Transducers and Activators of Transcription (STATs) Activation and …, 2003 | 6 | 2003 |
A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory E Gars, SM Yousry, D Babu, JH Kurzer, TI George, D Gratzinger Leukemia & Lymphoma 58 (7), 1730-1732, 2017 | 5 | 2017 |
Clinicopathologic and molecular analysis of normal karyotype therapy-related and de novo acute myeloid leukemia: a multi-institutional study by the bone marrow pathology group MD Cantu, R Kanagal-Shamanna, SA Wang, T Kadia, CE Bueso-Ramos, ... JCO Precision Oncology 7, e2200400, 2023 | 4 | 2023 |
Targeted mutational profiling reveals clonal relationships in metachronous occurrence of classic Hodgkin and mediastinal large B-cell lymphomas K Singh, LS Lezama, J Kurzer, J Oak, LM Schultz, A Walkush, TC Cheng, ... The American Journal of Surgical Pathology 47 (1), 81-90, 2023 | 4 | 2023 |